	US 12,419,938 B2
	Proenzyme composition
Julian Kenyon, Camberwell (AU); and Ralf Brandt, Camberwell (AU)
Assigned to Propanc Pty Ltd, Camberwell (AU)
Appl. No. 15/775,375
Filed by Propanc Pty Ltd, Camberwell (AU)
PCT Filed Nov. 11, 2016, PCT No. PCT/AU2016/051082 § 371(c)(1), (2) Date May 10, 2018, PCT Pub. No. WO2017/079802, PCT Pub. Date May 18, 2017.
Claims priority of provisional application 62/321,377, filed on Apr. 12, 2016.
Claims priority of application No. 2015904678 (AU), filed on Nov. 12, 2015.
Prior Publication US 2019/0262435 A1, Aug. 29, 2019
Int. Cl. A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01)

CPC A61K 38/4826 (2013.01) [A61K 9/0019 (2013.01); A61P 35/00 (2018.01); C12Y 304/21001 (2013.01); C12Y 304/21004 (2013.01)]

4 Claims

1. A method of treating cancer in a subject comprising administering chymotrypsinogen in an amount of 41 mg/kg and trypsinogen in an amount of is 6.75 mg/kg, thereby treating cancer in a subject.